BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 11192920)

  • 1. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
    Yildirim E; Celen O; Berberoglu U
    J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
    Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
    Volpe CM; Driscoll DL; Douglass HO
    Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical outcomes of gastrectomy with D1 lymph node dissection performed for patients with unfavorable clinical conditions.
    Ramos MFKP; Pereira MA; Dias AR; Yagi OK; Zaidan EP; Ribeiro-Júnior U; Zilberstein B; Cecconello I
    Eur J Surg Oncol; 2019 Mar; 45(3):460-465. PubMed ID: 30497814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching.
    Kang JH; Ryu SY; Jung MR; Jeong O
    Eur J Surg Oncol; 2020 Jul; 46(7):1239-1246. PubMed ID: 32331983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
    Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
    Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
    Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification.
    Roukos D; Schmidt-Mathiesen A; Encke A
    Surg Oncol; 1995; 4(6):323-32. PubMed ID: 8809955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefit of extended D2 resection for proximal gastric cancer.
    Volpe CM; Driscoll DL; Miloro SM; Douglass HO
    J Surg Oncol; 1997 Mar; 64(3):231-6. PubMed ID: 9121155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
    Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
    Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 Lymphadenectomy for Gastric Adenocarcinoma: Long-term Results and the Impact of Surgeon Experience on the Survival Rates.
    Tudor S; Dumitrascu T; Manuc M; Trandafir B; Ionescu M; Popescu I; Herlea V; Vasilescu C
    Chirurgia (Bucur); 2018; 113(6):772-779. PubMed ID: 30596365
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.
    Degiuli M; Sasako M; Ponti A; Calvo F
    Br J Cancer; 2004 May; 90(9):1727-32. PubMed ID: 15150592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node metastasis with adenocarcinoma of the gastric cardia: clinicopathological analysis and indication for D1 dissection.
    Shimada H; Suzuki T; Nakajima K; Hori S; Hayashi H; Takeda A; Arima M; Gunji Y; Koide Y; Ochiai T
    Int Surg; 1999; 84(1):13-7. PubMed ID: 10421011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.